Has Sonata Jodele received payments from drug or device companies?

Yes. Drug and device makers reported $112,954 in general payments to Sonata Jodele across 41 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sonata Jodele did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sonata Jodele come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sonata Jodele

Pediatric Hematology-Oncology · Cincinnati, OHNPI 1336179662

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $108,650 of the $112,954 with a category attached, or 96.2%. 7 manufacturers reported payments, led by Swedish Orphan Biovitrum AB at 43.4% of the total. Reporting peaked in 2021 at $48,500 and has fallen 98.5% since, to $738 in 2025. Among pediatric hematology-oncology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$112,954in general payments, 2019–2025

Across 41 payments — averaging $2754.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Swedish Orphan Biovitrum AB$49K
Omeros Corporation$36K
AstraZeneca$12K
Eli Lilly$9K
Sobi, Inc$5K
Novartis$2K
plus $147 from 1 others

$619,110in research payments, 2019–2025

Across 8 payments — averaging $77,389 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

AstraZeneca$607K
Swedish Orphan Biovitrum AB$10K
Omeros Corporation$2K

What the payments were for

Consulting fees$108,65096%
Travel & lodging$4420%
Food & beverage$1,8372%
Education$2,0252%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Swedish Orphan Biovitrum AB	6	$49,050
Omeros Corporation	5	$35,596
AstraZeneca	9	$11,865
Eli Lilly	3	$9,225
Sobi, Inc	16	$5,196
Novartis	1	$1,875
Jazz Pharmaceuticals Inc.	1	$147

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Empaveli$29,925
narsoplimab$11,250
Gamifant$4,642
OMIDRIA$241
RYLAZE$147

How this compares

$112,954 in reported general payments places this provider in the 95th percentile of 143 pediatric hematology-oncology providers in Ohio.

See all pediatric hematology-oncology providers in Ohio →

Other pediatric hematology-oncology in Cincinnati

Ashish KumarCincinnati$420K
Russell WareCincinnati$83K
Christopher DandoyCincinnati$78K
Eric MullinsCincinnati$78K
Pooja KhandelwalCincinnati$69K
Michael JordanCincinnati$61K
Michael GrimleyCincinnati$51K
Cristina TarangoCincinnati$34K
Anthony SabulskiCincinnati$32K
Adrienne HammillCincinnati$25K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →